The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#5RJDD)
This report describes ACIP's recommendation for the Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years.